Latest filing published 10 Aug 2012 for AMYLIN PHARMACEUTICALS INC, €1.8M.
No signal scores available.
Orville G. Kolterman is a declared insider of Amylin Pharmaceuticals Inc, with filings sourced from SEC (Form 4). The record holds 162 filings, for trades running from 3 January 2006 to 8 August 2012.
On the market, this insider has only sold: 61 sales, €8.0M in total. Outside the open market, there are 24 share grants and 70 option exercises. 2012 to date brings no purchases and 3 sales.
The record was last updated on 10 August 2012 with a transaction (€1.8M) in Amylin Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 154 declarations